Search Results
Apr 28, 2026, 16:05 ET PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
https://icd.who.int/browse10/2019/en#/G10. Accessed October 2021.Gatto EM, González Rojas N, Persi G, et al. Clin Parkinsonism Rel Disord 2020;3:100056.Tabrizi SJ, Flower MD, Ross CA, et al. Nat Rev Neurol 2020;16(10):529–546.Roos RAC. Orphanet
More news about: PTC Therapeutics, Inc.
Apr 28, 2026, 09:28 ET PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
https://icd.who.int/browse10/2019/en#/G10. Accessed October 2021.Gatto EM, González Rojas N, Persi G, et al. Clin Parkinsonism Rel Disord 2020;3:100056.Tabrizi SJ, Flower MD, Ross CA, et al. Nat Rev Neurol 2020;16(10):529–546.Roos RAC. Orphanet
More news about: PTC Therapeutics, Inc.
Apr 28, 2026, 09:00 ET Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
Hügli O, Togni M, Meier B. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004. Clin Res Cardiol. 2007;96(6):375-382. doi:10.1007/s00392-007-0513-0.
More news about: Abbott
Apr 27, 2026, 08:03 ET FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)
https://www.clinicaltrials.gov/study/NCT041190506 Tranekær S, Hansen DL, Frederiksen H. Epidemiology of secondary warm autoimmune haemolytic anaemia-A systematic review and meta-analysis. J Clin Med. 2021 Mar 17;10(6):1244. doi:10.3390/jcm10061244. PMID: 33802848; PMCID: PMC8002719.7 National Organization for Rare Disorders,
More news about: Johnson & Johnson
Apr 27, 2026, 08:00 ET FDA approves CAPLYTA® (lumateperone) sNDA with robust new data supporting reduced risk of relapse in schizophrenia
developments.Footnotesi Alphs L, et al. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable therapy. Int Clin Psychopharmacol. 2016;31(4)202-209. doi:10.1097/YIC.0000000000000125ii "Schizophrenia Fact Sheet." Treatment Advocacy Center,
More news about: Johnson & Johnson
Apr 23, 2026, 02:34 ET DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS
Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial. Clin Cancer Res. 2025 Sep 15;31(18):3907-3915. doi: 10.1158/1078-0432.CCR-25-0201. PMID: 40705396; PMCID: PMC12440240.
More news about: National University Cancer Institute, Singapore (NCIS)
Apr 21, 2026, 13:57 ET CLIN OPS SOLUTIONS EXPANDS INDUSTRY IMPPACT THROUGH EXCLUSIVE EVENTS, NETWORKING DINNERS, AND EXPERT-LED WEBINARS
is positioning itself as more than a staffing partner—it is becoming a connector of ideas, expertise, and innovation.About Clin Ops SolutionsClin Ops Solutions is a specialized recruitment firm supporting biotech and pharmaceutical companies in building high-performing clinical
More news about: Clin Ops Solutions
Apr 20, 2026, 08:00 ET Argo Biopharma Doses First Patients in Phase II Clinical Trials of siRNA Therapy BW-40202
clinical progression risk score. PLoS One 2012; 7(6): e38904.Pitcher D, Braddon F, Hendry B, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol 2023; 18: 727-38.Kwon CS, Daniele P, Forsythe A, Ngai C. A systematic literature review of the epidemiology, health-related
More news about: Argo Biopharmaceutical Co., Ltd
Apr 20, 2026, 08:00 ET Sapience Therapeutics Presents First Clinical Results from Phase 2 Study of ST316, First-in-Class β-catenin Antagonist, in Second-Line Colorectal Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2026
LinkedIn. _____________________________________________________________1 Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026; e70043. doi: 10.3322/caac.700432 Yaeger et al., Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal
More news about: Sapience Therapeutics, Inc.
Apr 20, 2026, 07:30 ET 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
FoundationAlhanshali L, Buontempo MG, Lo Sicco KI, Shapiro J. Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs. Clin Cosmet Investig Dermatol. 2023;16:803-820
More news about: Nektar Therapeutics
Apr 20, 2026, 06:45 ET U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
20MIBCvii Funt SA, Rosenberg JE. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol. 2017 Apr;14(4):221-234. doi: 10.1038/nrclinonc.2016.188. Epub 2016 Nov 22. PMID: 27874062; PMCID: PMC6054138.viii Squires P,
More news about: Astellas Pharma Inc.
Apr 17, 2026, 15:30 ET New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
treated for stage I or II cancer and achieved remission.Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;e70043. doi:
More news about: Abbott
Apr 17, 2026, 03:00 ET BIRKENSTOCK OUVRE SON PREMIER MAGASIN SUISSE À ZURICH
des produits qui caractérisent certains des produits préférés de la clientèle BIRKENSTOCK. Les luminaires alliant le liège et la toile de jute sont un clin d'œil au lit de pied de la marque, tout comme l'empreinte surdimensionnée représentée sur un mur.LE MARIAGE DE L'ICONIQUE ET DU CONTEMPORAINLe
More news about: BIRKENSTOCK Group
Apr 16, 2026, 09:04 ET NCCN Awards Grants to Improve Lung Cancer Screening Rates According to Guideline Recommendations
NCCN.org for more information.1 Siegel R, Kratzer T, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025; 75(1): 10-45. doi:10.3322/caac.21871.Media Contact:Rachel Darwin267-622-6624
More news about: National Comprehensive Cancer Network
Apr 15, 2026, 08:00 ET Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis
media 3.2-hrs faster.Fabre V, Carroll KC, Cosgrove SE. Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship. J Clin Microbiol. 2022 Mar 16;60(3):e0100521. doi: 10.1128/JCM.01005-21. Epub 2021 Jul 14. PMID: 34260274; PMCID: PMC8925908.Khare R, Kothari T, Castagnaro
More news about: Waters Corporation
Apr 11, 2026, 04:20 ET SINGAPORE STRENGTHENS SARCOMA CARE THROUGH COORDINATED, MULTIDISCIPLINARY APPROACH
[1] Source: Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2:14. https://doi.org/10.1186/2045-3329-2-14.
More news about: National University Cancer Institute, Singapore (NCIS)
Apr 10, 2026, 07:16 ET BD introduce un'innovazione TIPS di nuova generazione per migliorare il trattamento dell'ipertensione portale in tutta l'Unione Europea
2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 08:02 ET ProofPilot Announces 2nd CORE Symposium, Gathering Pharma and Biotech Leaders to Tackle Clinical Operations' Toughest Challenges
CORE is designed for clin ops leaders who are ready to move beyond the conversation and into action. Built for clin ops professionals who are responsible for executing the pipeline, navigating the real challenges of study
More news about: ProofPilot
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD stellt die nächste Generation der TIPS-Technologie vor, um die Behandlung der portalen Hypertonie in der gesamten Europäischen Union voranzubringen
2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD ofrece la tecnología TIPS para impulsar la atención de la hipertensión portal en toda la Unión Europea
2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD propose une innovation TIPS de nouvelle génération pour faire progresser les soins de l'hypertension portale dans l'Union européenne
10.1371/journal.pone.0328492 Carroll A, Boike JR. Conseils pour les bénéficiaires de TIPS : Un guide sur les TIPS axé sur le patient. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 07, 2026, 08:00 ET Royal Biologics Announces FDA Clearance for Fibrinet® PRF Wound Matrix for the Management of Cutaneous Wounds
J. A Prospective Study to Evaluate Efficacy and Safety of Autologous Platelet-Rich Fibrin Matrix for the Treatment of Chronic Diabetic Foot Ulcers. Clin Res Foot Ankle. 2024;12:590. doi:10.4172/2329-910X.1000590.Media ContactMary Jo Murino
More news about: Royal Biologics
Apr 06, 2026, 19:00 ET Hon Hai Technology Group (Foxconn) met à l'honneur 152 de ses membres et fournisseurs lors des 3e Annual Sustainability Awards
TAIPEI, 7 avril 2026 /PRNewswire/ -- Dans un clin d'œil à l'innovation en matière de durabilité, Hon Hai Technology Group (« Foxconn ») (TWSE:2317) a récompensé 152 équipes et projets lors des « Hon Hai-Foxconn Sustainability
More news about: Hon Hai Technology Group (Foxconn)